You are here

  • Home
  • Archive
  • Volume 7, Issue 2
  • Assessing the potential clinical impact of reciprocal drug approval legislation on access to novel therapeutics in the USA: a cohort study

Article metrics

Article menu

Download PDFPDF

XML
Health policy
Research
Assessing the potential clinical impact of reciprocal drug approval legislation on access to novel therapeutics in the USA: a cohort study

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 2018686820
Feb 2018878218
Mar 2018686823
Apr 2018595919
May 2018777815
Jun 201816216315
Jul 201811911917
Aug 2018979823
Sep 2018878711
Oct 201812312446
Nov 2018636514
Dec 2018535316
Jan 2019484811
Feb 2019575916
Mar 2019898914
Apr 2019686820
May 2019828227
Jun 2019595910
Jul 2019676714
Aug 2019505013
Oct 2019888817
Nov 2019626219
Dec 2019646411
Jan 2020767613
Feb 202062628
Mar 2020595918
May 2020646411
Jun 202040407
Jul 202056547
Aug 202051507
Sep 2020616116
Oct 2020494913
Nov 2020434321
Dec 2020848237
Jan 2021413918
Feb 2021434314
Mar 2021565622
Apr 202147497
May 2021515016
Jun 2021515112
Jul 202160608
Aug 2021444211
Sep 2021454515
Oct 2021514629
Nov 20213030426
Dec 2021242422
Jan 202236338
Feb 202220186
Mar 2022757715
Apr 202238364
May 2022211914
Jun 202215147
Jul 202220214
Aug 2022232236
Sep 2022171417
Oct 2022272710
Nov 20229912
Dec 2022111023
Jan 202316149
Feb 2023111125
Mar 20238891174
Apr 2023212178
May 202314155
Jun 202327276
Jul 202324237
Aug 2023212113
Sep 202316168
Oct 202331251
Nov 2023151513
Dec 202333316
Jan 202419199
Feb 2024464615
Mar 2024454455
Apr 2024252319
Total374937171766